Sprim Als Blog ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally

July 25, 2024 - (PRNewswire) - ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests across the cancer research and care continuum. ... Read More The post ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally appeared first on SPRIM.